Effect of Plasma Amino Acid Replacement on Glucagon and Substrate Responses to Insulin-Induced Hypoglycemia in Humans

A defective glucagon response impairs glucose recovery from insulin-induced hypoglycemia in some insulin-dependent (type I) diabetic patients. Our objective was to determine whether the glucagon reponse to insulin-induced hypoglycemia could be stimulated in nondiabetic humans. Because insulin reduces plasma amino acid concentrations, and amino acids are known to stimulate glucagon secretion, we investigated the effect of amino acid replacement during insulin infusion on the glucagon response to hypoglycemia in six healthy nondiabetic subjects. In two separate studies, blood glucose was clamped at the postabsorptive level during a constant infusion of insulin (0.05 U · kg−1 · h−1) for 3 h. Blood glucose was then reduced to 45 mg/dl over 20 min. Hormone and substrate concentrations during recovery from hypoglycemia were monitored for 2 h. In the control study, normal saline was infused, and in the other study, an amino acid mixture was infused to prevent the insulin-induced fall in plasma amino acids. Amino acid replacement did not change the basal glucagon levels but resulted in a more robust glucagon response to hypoglycemia (from 184 ± 24 to 292 ± 36 pg/ml) than in the control study (from 176 ± 30 to an average 229 ± 32 pg/ml, P < 0.01). Plasma concentrations of epinephrine, norepinephrine, cortisol, and growth hormones increased during hypoglycemia, but the magnitude of the response was not different between the control and amino acid-replacement studies. Amino acid replacement did not affect glucose recovery but inhibited the recovery of plasma concentrations of free fatty acids, glycerol, and β-hydroxybutyrate. We conclude that the glucagon response to insulin-induced hypoglycemia is enhanced by amino acid replacement in humans and that changes in plasma amino acid concentrations modulate the effect of stress hormones on lipid metabolism during hypoglycemia.

[1]  W. Tamborlane,et al.  Oxidative fuel metabolism during mild hypoglycemia: critical role of free fatty acids. , 1989, The American journal of physiology.

[2]  W. Tamborlane,et al.  Hypoglycemia and glucose counterregulation in normal and insulin-dependent diabetic subjects. , 1988, Diabetes/metabolism reviews.

[3]  K. Nair,et al.  Effect of intravenous insulin treatment on in vivo whole body leucine kinetics and oxygen consumption in insulin-deprived type I diabetic patients. , 1987, Metabolism: clinical and experimental.

[4]  N. Abumrad,et al.  Glutamine blocks lipolysis and ketogenesis of fasting. , 1986, The American journal of physiology.

[5]  D. W. Foster From Glycogen to Ketones—And Back , 1984, Diabetes.

[6]  P. Cryer,et al.  Defective glucose counterregulation limits intensive therapy of diabetes mellitus. , 1984, The American journal of physiology.

[7]  M. Haymond,et al.  Effects of free fatty acid availability, glucagon excess, and insulin deficiency on ketone body production in postabsorptive man. , 1983, The Journal of clinical investigation.

[8]  P. Brunetti,et al.  Abnormal Glucose Counterregulation in Insulin-dependent Diabetes Mellitus: Interaction of Anti-Insulin Antibodies and Impaired Glucagon and Epinephrine Secretion , 1983, Diabetes.

[9]  R. Unger Special Comment: Meticulous Control of Diabetes: Benefits, Risks, and Precautions , 1982, Diabetes.

[10]  K. Alberti,et al.  The antiketogenic effect of alanine in normal man: evidence for an alanine-ketone body cycle. , 1981, Metabolism: clinical and experimental.

[11]  R. Campbell,et al.  Counterregulatory Hormonal Responses to Rapid Glucose Lowering in Diabetic Man , 1979, Diabetes.

[12]  R. DeFronzo,et al.  Glucose clamp technique: a method for quantifying insulin secretion and resistance. , 1979, The American journal of physiology.

[13]  F. H. Walters,et al.  High performance liquid chromatographic determination of amino acids in the picomole range. , 1979, Analytical chemistry.

[14]  R. Rizza,et al.  Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia. , 1979, The Journal of clinical investigation.

[15]  K. Alberti,et al.  Enzymic fluorometric continuous-flow assays for blood glucose, lactate, pyruvate, alanine, glycerol, and 3-hydroxybutyrate. , 1978, Clinical chemistry.

[16]  D. Kipnis,et al.  In-vivo Measurement of Glucose and Alanine Metabolism with Stable Isotopic Tracers , 1977, Diabetes.

[17]  J. Gerich,et al.  Lack of Glucagon Response to Hypoglycemia in Diabetes: Evidence for an Intrinsic Pancreatic Alpha Cell Defect , 1973, Science.

[18]  M. Vranic,et al.  Effect of Arginine on Glucose Turnover and Plasma Free Fatty Acids in Normal Dogs , 1973, Diabetes.

[19]  D. M. Rocha,et al.  Glucagon-stimulating activity of 20 amino acids in dogs. , 1972, The Journal of clinical investigation.

[20]  R. Unger,et al.  The role of aminogenic glucagon secretion in blood glucose homeostasis. , 1969, The Journal of clinical investigation.

[21]  R. Steele,et al.  INFLUENCES OF GLUCOSE LOADING AND OF INJECTED INSULIN ON HEPATIC GLUCOSE OUTPUT * , 1959, Annals of the New York Academy of Sciences.

[22]  K. Minaker,et al.  Insulin dose-dependent reductions in plasma amino acids in man. , 1986, The American journal of physiology.

[23]  A. Puech,et al.  Decreased beta-adrenergic sensitivity in insulin-dependent diabetic subjects. , 1986, The Journal of clinical endocrinology and metabolism.

[24]  J. Aikens,et al.  A microfluorometric method for the determination of free fatty acids in plasma. , 1983, Journal of lipid research.

[25]  B. Jaffe,et al.  Methods of Hormone Radioimmunoassay , 1974 .

[26]  R. Steele,et al.  ON THE HORMONAL REGULATION OF CARBOHYDRATE METABOLISM; STUDIES WITH C14 GLUCOSE. , 1963, Recent progress in hormone research.

[27]  H. Krebs,et al.  Enzymic determination of D(-)-beta-hydroxybutyric acid and acetoacetic acid in blood. , 1962, The Biochemical journal.